首页>投融资
AtaCor Medical
C轮
成立于2014年的AtaCor Medical正在改变心脏起搏器。
AtaCor的心脏外起搏导线的设计无需任何医学成像即可插入，从而实现了更快、侵入性更小的治疗。独特的位置避免了需要进入患者血管系统的需要，并且使患者心脏完全不受影响。此外，心外导联被设计为消除与临时起搏相关的卧床限制，从而改善患者的活动能力和术后恢复。
AtaCor的管理团队由可植入心脏设备和电生理领域的资深专家组成，他们具有八十多年的综合经验。
基本信息
-
公司全称AtaCor Medical Inc
-
类型心脏起搏器研发商
-
产业领域医疗器械、治疗设备
-
公司人数15人以下
-
地址635 CAMINO DE LOS MARES, SUITE 205, SAN CLEMENTE
-
联系电话19494821038
-
邮箱INFO@ATACOR.COM
-
成立时间2014-01-01
投融资
-
2024-04-24C轮2800万美元Arboretum VenturesLongview VenturesHatteras Venture PartnersCatalyst Health VenturesBaymed Venture Partners
-
2020-04-28B轮2500万美元aMoonCatalyst Health VenturesLongview VenturesBroadview VenturesHatteras Venture Partners
-
2018-09-18A轮900万美元Broadview VenturesaMoon
相关投融资企业
C轮
Francis Medical is a dynamic medical device company committed to developing urological cancer treatments that are tough on cancer yet gentle on patients.In September 2020, Coloplast announced that it has completed a USD 4m (DKK 25m) equity investment in Francis Medical
收并购
Gynesonics is a developer of transcervical, uterus-preserving, incision-free technologies for diagnostic and therapeutic applications (avoiding invasive surgical techniques of hysterectomy or myomectomy for symptomatic uterine fibroids). Products include the Sonata system which combines intrauterine ultrasound guidance with targeted radiofrequency ablation.In April 2023, the company closed a financing round of $25M
未公开
BetaGlue Therapeutics是一家临床分期肿瘤公司，该公司开发了一种先进的放疗平台，能够对不可切除的实体瘤和手术切缘进行局部靶向治疗，称为YntraDose。
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息